Vanguard Group’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.3M Buy
2,170,028
+122,463
+6% +$2.5M ﹤0.01% 2180
2025
Q1
$41M Buy
2,047,565
+215,030
+12% +$4.3M ﹤0.01% 2174
2024
Q4
$48.8M Buy
1,832,535
+83,783
+5% +$2.23M ﹤0.01% 2167
2024
Q3
$49.9M Buy
1,748,752
+171,238
+11% +$4.88M ﹤0.01% 2180
2024
Q2
$34.3M Buy
1,577,514
+83,338
+6% +$1.81M ﹤0.01% 2300
2024
Q1
$33.1M Buy
1,494,176
+32,695
+2% +$724K ﹤0.01% 2354
2023
Q4
$31.5M Buy
1,461,481
+22,093
+2% +$477K ﹤0.01% 2383
2023
Q3
$24.3M Buy
1,439,388
+11,967
+0.8% +$202K ﹤0.01% 2471
2023
Q2
$19.6M Buy
1,427,421
+23,520
+2% +$323K ﹤0.01% 2597
2023
Q1
$31.9M Buy
1,403,901
+11,177
+0.8% +$254K ﹤0.01% 2389
2022
Q4
$32.8M Buy
1,392,724
+141,991
+11% +$3.34M ﹤0.01% 2380
2022
Q3
$32.6M Buy
1,250,733
+39,937
+3% +$1.04M ﹤0.01% 2396
2022
Q2
$26.6M Buy
1,210,796
+34,569
+3% +$759K ﹤0.01% 2508
2022
Q1
$52.8M Buy
1,176,227
+13,386
+1% +$601K ﹤0.01% 2279
2021
Q4
$49.9M Sell
1,162,841
-3,347
-0.3% -$143K ﹤0.01% 2355
2021
Q3
$77.6M Buy
1,166,188
+38,996
+3% +$2.59M ﹤0.01% 2127
2021
Q2
$82.7M Buy
1,127,192
+112,070
+11% +$8.22M ﹤0.01% 2102
2021
Q1
$69.5M Buy
1,015,122
+84,597
+9% +$5.79M ﹤0.01% 2133
2020
Q4
$62.5M Buy
930,525
+276,466
+42% +$18.6M ﹤0.01% 2082
2020
Q3
$33.7M Buy
654,059
+112,310
+21% +$5.78M ﹤0.01% 2220
2020
Q2
$20.4M Buy
541,749
+322,259
+147% +$12.1M ﹤0.01% 2417
2020
Q1
$6.54M Buy
219,490
+18,988
+9% +$566K ﹤0.01% 2827
2019
Q4
$6.89M Buy
200,502
+87,589
+78% +$3.01M ﹤0.01% 3041
2019
Q3
$2.04M Buy
+112,913
New +$2.04M ﹤0.01% 3444